To improve patient life expectancy by providing innovative targeted radiotheranostics and acceleration of discoveries in nuclear medicine.
At RadioMedix, Inc., our leadership team is dedicated to pioneering advancements in targeted radiopharmaceuticals for cancer diagnosis, monitoring, and therapy. Based in Texas, our clinical-stage biotechnology company thrives on innovation and excellence. Our team brings together a wealth of experience and expertise in the fields of radiopharmaceuticals, PET imaging, and targeted alpha and beta-emitter therapy.
At RadioMedix, Inc., we are at the forefront of innovation in targeted radiopharmaceuticals for cancer diagnosis, monitoring, and therapy. Our team is passionate about making a difference in the lives of patients through cutting-edge science and technology. We are always looking for talented and dedicated individuals to join our mission-driven team.
